Skip to main content

Table 2 Response rates of cetuximab in combination with S-1 and oxaliplatin (Ce-SOX) and S-1 and oxaliplatin (SOX) groups

From: Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer

Response

Ce-SOX

SOX

P

Complete response

1

0

-

Partial response

16

11

0.11

Stable disease

10

8

0.18

Progressive disease

4

6

0.15

Response rate (%)

54.8

44.0

0.22

Disease control rate (%)

87.1

76.0

0.16